Skip to content

Mothers after Gestational Diabetes in Australia (MAGDA)

Mothers After Gestational Diabetes in Australia (MAGDA) study. Preventing diabetes in pregnancy from progressing to type 2 diabetes.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000338066
Acronym
MAGDA
Enrollment
574
Registered
2010-04-28
Start date
2012-07-25
Completion date
2014-06-25
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A very strong predictor for developing diabetes is having diabetes during pregnancy. In the vast majority of cases, pregnancy diabetes resolves after the delivery of the baby, but these women are then at high risk of subsequently developing type 2 diabetes. This project aims to reduce this risk. Women who have developed diabetes during pregnancy will be invited to take part. A lifestyle modification program will be developed and evaluated for these women so that their risk of progressing to diabetes is reduced. Reduced risk will be assessed by monitoring clinical and behavioural outcomes of participants in the lifestyle program before and after completion (particularly any reduction in diabetes risk, weight and central body obesity, and changes in quality of life) and by comparing these with another group receiving usual care at the same time.

Interventions

A six session group behaviour intervention program was run.The first session, an individual session with participant and facilitator, a risk assessment and goal setting session was facilitatored either face to face or over the phone, if difficulties meeting up arose. The individual session took up to an hour to complete. The remaining 5 sessions commenced two weeks after the individual session and were group based, at two week intervals. Topics included: physical activity, fats, fibre, sleep. Ea

A six session group behaviour intervention program was run.The first session, an individual session with participant and facilitator, a risk assessment and goal setting session was facilitatored either face to face or over the phone, if difficulties meeting up arose. The individual session took up to an hour to complete. The remaining 5 sessions commenced two weeks after the individual session and were group based, at two week intervals. Topics included: physical activity, fats, fibre, sleep. Each session was run for approximately 2 hours, each with up to 12 participants. The sessions were run by specially trained facilitators who have a health-related background, the intention was to have the same facilitator run all the sessions for the same group, independently as to build a rapport with the participants. Along with the topics listed before each session covered goal setting, motivation and managing setbacks. At three and six months, there was a telephone follow up, maintenance sessions with the same facilitator that took the group sessions. An additional amendment allowed a small group of women in the study (31) to receive a telephone based lifestyle intervention program. These participants had NOT attended the MAGDA face to face group intervention. To differentiate this group the intervention was called TeleMAGDA. The intervention was based on the same topics as the group based MAGDA program but was done over seven, individual, 30-60 minute telephone coaching sessions, again one every 2 weeks. As for MAGDA the phone coach/facilitator was run by specially trained facilitators who had a health-related background, the intention was to have the same facilitator run all the sessions for the same individual.

Sponsors

James Dunbar
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Women with a diagnosis of Gestational Diabetes who gave birth after 1/1/2007 at participating hospitals will be invited to participate. All potential participants will have an oral glucose tolerance test to confirm that they do not have diabetes prior to entering the study.

Exclusion criteria

*Established diabetes (T1DM or T2DM) *Severe mental illness in the last three months *Substance abuse (illicit drugs) in the last three months *Myocardial infarction in the last three months *Difficulty with English *Pregnant at any time during the study (from baseline screening to 12 months post-baseline *Involved in a post-natal lifestyle-based intervention or a similar clinical trial which may impact primary clinical outcomes *Surgical or medical intervention to treat obesity

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 1, 2026